-
After delayed IPO, Mereo gets US listing via OncoMed merger
pharmaphorum
December 10, 2018
UK biotech Mereo BioPharma is merging with Californian biotech OncoMed in an all-stock deal that swells its pipeline and gives it a potential licensing deal with Celgene......
-
M&As : GlaxoSmithKline, Takeda, Procter & Gamble
pharmaceutical-technology
December 10, 2018
GlaxoSmithKline (GSK) has agreed to acquire US-based cancer treatment developer Tesaro for $5.1bn.GSK will acquire all issued and outstanding.....
-
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
worldpharmanews
December 07, 2018
The proposed transaction will significantly strengthen GSK's pharmaceutical business, accelerating the build of GSK's pipeline and commercial capability in oncology.
-
Takeda receives shareholders’ approval to acquire Shire
pharmaceutical-technology
December 06, 2018
Takeda Pharmaceutical has secured shareholder approval for the issuance of its shares necessary to implement the proposed $62bn acquisition of Shire....
-
GSK enters PARP space with TESARO acquisition
pharmaphorum
December 05, 2018
GSK has announced that it will acquire US-based oncology specialist TESARO for $5.1 billion, gaining access to its PARP inhibitor Zejula (niraparib).....
-
P&G completes Merck’s Consumer Health unit acquisition for $3.8bn
pharmaceutical-technology
December 04, 2018
Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal.The acquisition was announced in April......
-
Tris Pharma Expands ADHD Portfolio with Acquisition of NextWave Pharmaceuticals
pharmafocusasia
December 03, 2018
Tris Pharma, Inc. (Tris), a pharmaceutical company focused on developing innovative technology-based therapeutic products that address unmet patient needs....
-
Roche subsidiary Genentech to acquire Jecure Therapeutics
pharmaceutical-technology
November 30, 2018
Swiss firm Roche Group’s affiliate Genentech has agreed to acquire US biotechnology company Jecure Therapeutics to strengthen its position in the treatment of liver diseases.....
-
CVS Health completes acquisition of Aetna for $69bn
pharmaceutical-technology
November 30, 2018
CVS Health has completed its acquisition of all outstanding shares of healthcare benefits provider Aetna in a deal valued at $69bn......
-
WuXi NextCODE Invests $400M to Expand Precision Medicine Efforts in Ireland
contractpharma
November 30, 2018
WuXi NextCODE, a life sciences informatics company, has unveiled its plan to create in Ireland a dataset for genome-driven drug discovery and create a model for delivering the benefits of precision medicine.